ES502856A0 - Un procedimiento para la preparacion de dipeptido-2-amino-1,2-didesoxi-d-glucosas, inmunologicamente activas. - Google Patents

Un procedimiento para la preparacion de dipeptido-2-amino-1,2-didesoxi-d-glucosas, inmunologicamente activas.

Info

Publication number
ES502856A0
ES502856A0 ES502856A ES502856A ES502856A0 ES 502856 A0 ES502856 A0 ES 502856A0 ES 502856 A ES502856 A ES 502856A ES 502856 A ES502856 A ES 502856A ES 502856 A0 ES502856 A0 ES 502856A0
Authority
ES
Spain
Prior art keywords
immunologically active
glucosas
dipeptido
didesoxi
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502856A
Other languages
English (en)
Other versions
ES8207512A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8207512A1 publication Critical patent/ES8207512A1/es
Publication of ES502856A0 publication Critical patent/ES502856A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
ES502856A 1980-06-09 1981-06-08 Un procedimiento para la preparacion de dipeptido-2-amino-1,2-didesoxi-d-glucosas, inmunologicamente activas. Granted ES502856A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/157,906 US4315913A (en) 1980-06-09 1980-06-09 Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation

Publications (2)

Publication Number Publication Date
ES8207512A1 ES8207512A1 (es) 1982-10-01
ES502856A0 true ES502856A0 (es) 1982-10-01

Family

ID=22565821

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502856A Granted ES502856A0 (es) 1980-06-09 1981-06-08 Un procedimiento para la preparacion de dipeptido-2-amino-1,2-didesoxi-d-glucosas, inmunologicamente activas.

Country Status (10)

Country Link
US (1) US4315913A (es)
EP (1) EP0041896B1 (es)
JP (1) JPS5726698A (es)
AT (1) ATE5716T1 (es)
CA (1) CA1173430A (es)
DE (1) DE3161775D1 (es)
DK (1) DK246181A (es)
ES (1) ES502856A0 (es)
GR (1) GR74573B (es)
PT (1) PT73126B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
ZA853989B (en) * 1984-05-29 1986-01-29 Ciba Geigy Ag Acylated sugar derivatives,processes for their manufacture,and their use
US4640911A (en) * 1985-05-29 1987-02-03 Ciba-Geigy Corporation Acylated sugar derivatives, processes for their manufacture, and their use
JPS61275299A (ja) * 1985-05-29 1986-12-05 Akira Hasegawa デオキシムラミルジペプチド誘導体
JPS61276873A (ja) * 1985-05-31 1986-12-06 Sony Chem Kk 導電異方性接着剤
US4868157A (en) * 1987-10-05 1989-09-19 Merck & Co., Inc. Dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives as host resistance enhancers in AIDS-immunocompromised hosts and methods of use
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
US6488929B2 (en) 1994-05-23 2002-12-03 Montana State University Candida albicans phosphomannan complex as a vaccine
WO1995031998A1 (en) * 1994-05-23 1995-11-30 The Research & Development Institute, Inc. Candida albicans adhesin as a vaccine
US6309642B1 (en) 1997-04-28 2001-10-30 The Research And Development Institute, Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
US20030072775A1 (en) * 1997-04-28 2003-04-17 The Research And Development Institute Inc. Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
ES2930246T3 (es) 2015-12-10 2022-12-09 Bharat Biotech Int Ltd Nuevo compuesto derivado del péptido muramilo, síntesis y utilizaciones del mismo
EP3389643B1 (en) 2015-12-15 2023-05-03 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2288527A2 (fr) 1974-10-22 1976-05-21 Anvar Compositions contenant de la n-acetyl-muramyl- l-alanyl - d-isoglutamine ou de l'acide n-acetyl-muramyl-l-alanyl - d-glutamique, exemptes d'huile et ayant des proprietes adjuvantes
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
US4083736A (en) * 1977-03-09 1978-04-11 Seaquist Valve Company, Div. Of Pittway Corporation Filter mounting apparatus

Also Published As

Publication number Publication date
ES8207512A1 (es) 1982-10-01
JPS5726698A (en) 1982-02-12
PT73126B (en) 1985-12-20
GR74573B (es) 1984-06-29
DK246181A (da) 1981-12-10
EP0041896A1 (en) 1981-12-16
CA1173430A (en) 1984-08-28
ATE5716T1 (de) 1984-01-15
US4315913A (en) 1982-02-16
EP0041896B1 (en) 1983-12-28
DE3161775D1 (en) 1984-02-02
PT73126A (en) 1981-07-01

Similar Documents

Publication Publication Date Title
ES502856A0 (es) Un procedimiento para la preparacion de dipeptido-2-amino-1,2-didesoxi-d-glucosas, inmunologicamente activas.
FI842992A0 (fi) Immunologiskt definitionsfoerfarande.
BE877926A (fr) Procede de determination immunologique d'anticorps specifiques d'une classe d'antigenes
IE822629L (en) N-aminoalkyl iodothyronines
IL69861A0 (en) Immunoassay of antigens
DE3679877D1 (de) Immunologisches testverfahren fuer htlv-iii-antigene.
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
IT1139491B (it) Metodo immunoenzimatico competitivo per la determinazione di antigeni
ES528000A0 (es) Un procedimiento para la purificacion de un antigeno.
ES515132A0 (es) "procedimiento para la determinacion de un antigeno carcinoembrionico".
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
IT1197625B (it) Antigene di picornavirus sintetico
IT1114209B (it) Determinazione di antigeni oppure di anticorpi
IT8720842A0 (it) Analisi immunologiva stratificata impiegando anticorpi legati a particelle di trasporto per determinare la presenza di un antigene.
ES541102A0 (es) Procedimiento para la valoracion inmunologica de una subs- tancia, especialmente un antigeno un hapteno o un anticuerpo
DK504389D0 (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
IT1153188B (it) Procedimento immunoenzimatico per il rilevamento di anticorpi antinucleari
ES552781A0 (es) Procedimiento para la obtencion de un anticuerpo monoclonal anti-alfa-amilasa
ATE28937T1 (de) Immunotest fuer kohlehydrat-antigen-determinant.
DK0537168T3 (da) Antigenet CTAA 28A32, som genkendes af MCA 28A32
IT1141277B (it) Polipeptide sintetico attivo come antigene,e procedimento per la sua preparazione
JPS52104236A (en) Toner fixing device
ES518127A0 (es) Procedimiento de preparacion de un antigeno toxoplasmico.
IT1126757B (it) Antigene per preparare l'anticorpo per saggio
MX170503B (es) , "procedimiento para obtener un reactivo antigenico util para determinar indirectamente salmonella typhi.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401